Manufacturer record
Bal Pharma Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Bal Pharma Limited (Uttarakhand) were declared Not of Standard Quality between February 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
6 records linked to Bal Pharma Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Diclofenac Gastro-Resistant Tablets IP | 250264AMfg 2025-05 · Exp 2028-04 | The sample does not conform to I.P 2022 with respect to test for Related substancesRelated substances | CDTL, MumbaiCDSCO lab | Jul 2026 |
| Secremet -1 (Metformin Hydrochloride Prolonged-Release & Glimepiride Tablets I.P.) | 210110Mfg 2021-02 · Exp 2023-01 | Assay of GlimepirideAssay | CDL KolkataCDSCO lab | Feb 2022 |
| Balgesic Plus (Aceclofenac & Paracetamol Tablets) | 200291Mfg 2021-08 · Exp 2023-07 | Assay of AceclofenacAssay | CDL KolkataCDSCO lab | Feb 2022 |
| ULTRAFLOX-500 (Ciprofloxacin Tablets I.P.) | 190112AMfg 2019-01 · Exp 2021-12 | DissolutionDissolution | CDL KolkataCDSCO lab | Apr 2021 |
| OMEP (Omeprazole Capsule I.P. 20mg) | UOME 1803Mfg 2018-02 · Exp 2020-01 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2019 |
| Omeprazole Capsules I.P. 20 mg. (OMEP) | UOME1801Mfg 2018-02 · Exp 2020-01 | DissolutionDissolution | Drugs Control Department, TripuraCDSCO lab | Feb 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.